FDA approves 2 gene therapies for sickle cell. One is the first to use the editing tool CRISPR

U.S. regulators have approved two gene therapies for sickle cell disease. Doctors hope they can cure the painful inherited blood disorder that afflicts mostly Black people in the U.S.

Related Keywords

Kentucky ,United States ,Bahrain ,United Kingdom ,Britain ,Benjamin Watkins ,Nicole Verdun ,Monica Bhatia ,Jalen Matthews ,Science Department ,Vertex Pharmaceuticals ,Howard Hughes Medical Institute Science ,Medicaid Services ,Drug Administration ,Us Centers For Medicare ,Sickle Cell Association Of Kentuckiana ,Educational Media Group ,Nobel Prize ,Bluebird Bio ,Hospital New ,Sickle Cell Association ,Associated Press Health ,Howard Hughes Medical Institute ,Educational Media ,